TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00523549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03730935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05062811 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00549770 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01777997 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05767814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05767814 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT01878604 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study NCT03446417 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03446417 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03487263 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03464916 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01522430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01291836 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03813381 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT03118830 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01662947 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00333229 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00333229 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04915781 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02285985 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02285985 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00005478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05386459 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02183324 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02571894 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05233553 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01262118 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01645475 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00001440 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03758456 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT00662584 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01171209 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01009138 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02974725 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02974725 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01650935 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT00504413 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT00504413 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00504413 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT02772016 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT01419977 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00942578 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03245463 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01291888 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03113604 — Predictive Biomarker (PRD): ABCG2 mRNA
Genes: ABCG2; ABCP; BCRP; BCRP1; MXR
Study NCT03113604 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study NCT04400929 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03519503 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02350491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01672866 — Predictive Biomarker (PRD): LOXL2 mRNA
Genes: LOXL2
Study NCT04593641 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00001623 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001623 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04240314 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03995537 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study NCT02042989 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03618810 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01187810 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT01768936 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00562042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02584920 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02584920 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02450097 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02483598 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02821104 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT03266562 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03266562 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01220856 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00604617 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03051594 — Surrogate Endpoint (SUR): Bacterial count
Study NCT02356484 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00705575 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00618917 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03897361 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03897361 — Predictive Biomarker (PRD): CTNS mRNA
Genes: CTNS
Study NCT03897361 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT02037256 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03259711 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00953797 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00343187 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00343187 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04006158 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02633397 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02530996 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00358098 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT00358098 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00358098 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00358098 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04608422 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03083223 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02063763 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03068299 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03428516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01819337 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00779935 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00779935 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04084951 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05468294 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01158625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01567774 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02048371 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02108691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00491881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00152061 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01076673 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00709878 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00709878 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04382768 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00123604 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00351325 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT02687516 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02687516 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02687516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03764930 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT01384032 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01384032 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00373945 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT02442700 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02442700 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01581203 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT00944996 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00944996 — Safety Biomarker (SAF): BDNF
Study NCT02965885 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02965885 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02965885 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04437992 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT02772926 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT02772926 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03013049 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02283424 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00097890 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT01798446 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04638608 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03126799 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03126799 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03158935 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03158935 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01451281 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00185601 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01756118 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT01756118 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00687102 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03864913 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01357317 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00130910 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04832945 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01352520 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01648868 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03393507 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02653677 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01447303 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01554514 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT00300365 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00641082 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03255876 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03169257 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT03169257 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01875341 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00384865 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03376698 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03376698 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00043186 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00732121 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00732121 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00732121 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03176732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02358889 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01850004 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01850004 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00082641 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01330823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01306474 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02314364 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02314364 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02314364 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT02314364 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02314364 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02900170 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02900170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04928729 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05373732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02981966 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00442325 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00466960 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00429078 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00508612 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00559130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04070729 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02830009 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT03174535 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04227223 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03545126 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00917462 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT02176382 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02765464 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT02896270 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03106298 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT03168100 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT02163798 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02163798 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04527068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04527068 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00822666 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00936026 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01728155 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT02699905 — Predictive Biomarker (PRD): FFAR2 mRNA
Genes: FFAR2; FFA2; GPCR43; GPR43
Study NCT03042312 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03307031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04257578 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03991741 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01860807 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04147936 — Surrogate Endpoint (SUR): Plasma ammonia
Study NCT04267471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03544229 — Safety Biomarker (SAF): DRD2
Study NCT03361098 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06065592 — Predictive Biomarker (PRD): CDKN2B mRNA
Genes: CDKN2B; MTS2
Study NCT01357161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01357161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01001962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03231904 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT01399268 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06055660 — Predictive Biomarker (PRD): MSN mRNA
Genes: MSN
Study NCT02529657 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02529657 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04642703 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00030537 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02568488 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02568488 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT04240236 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00827775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02198261 — Predictive Biomarker (PRD): SULT1A1 mRNA
Genes: SULT1A1; STP; STP1; OK/SW-cl.88
Study NCT03327168 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT01465802 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01355913 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02126072 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00722644 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00199888 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT03754023 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT03754023 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT03899116 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03863782 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02910401 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03597282 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT04208087 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT02738775 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01339533 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00677547 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT00677547 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02502981 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02774655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02795286 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00976586 — Predictive Biomarker (PRD): IKBKG mRNA
Genes: IKBKG; FIP3; NEMO
Study NCT01123824 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04068909 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT01954316 — Predictive Biomarker (PRD): PLK4 mRNA
Genes: PLK4; SAK; STK18
Study NCT01980524 — Predictive Biomarker (PRD): MYCL mRNA
Genes: MYCL; BHLHE38; LMYC; MYCL1
Study NCT01980524 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03964922 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03063541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03377335 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT01972789 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01972789 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study NCT01685021 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06484361 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03398421 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02412111 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00788164 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02782026 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT00103792 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT03296696 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02700230 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03411798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03849768 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06382571 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06382571 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1